scispace - formally typeset
M

Mark Armanini

Researcher at Genentech

Publications -  44
Citations -  17570

Mark Armanini is an academic researcher from Genentech. The author has contributed to research in topics: Neurotrophic factors & Glial cell line-derived neurotrophic factor. The author has an hindex of 35, co-authored 44 publications receiving 17137 citations.

Papers
More filters
Journal ArticleDOI

Inhibition of vascular endothelial growth factor-induced angiogenesis suppresses tumour growth in vivo

TL;DR: It is demonstrated that inhibition of the action of an angiogenic factor spontaneously produced by tumour cells may suppress tumour growth in vivo.
Journal ArticleDOI

GDNF: a potent survival factor for motoneurons present in peripheral nerve and muscle

TL;DR: Glial cell line-derived neurotrophic factor (GDNF), originally identified as a trophic factor specific for dopaminergic neurons, was found to be 75-fold more potent than the neurotrophins in supporting the survival of purified embryonic rat motoneurons in culture and to be a good candidate for treatment of motoneuron disease.
Journal ArticleDOI

Renal and neuronal abnormalities in mice lacking GDNF.

TL;DR: It is shown that at postnatal day 0 (P0), GDNF-deficient mice have deficits in dorsal root ganglion, sympathetic and nodose neurons, but not in hindbrain noradrenergic or midbrain dopaminergic neurons, and GDNF is important for the development and/or survival of enteric, sympathetic, and sensory neurons and the renal system, but is not essential for catecholaminergic neuron in the central nervous system (CNS).
Journal ArticleDOI

The tumour-suppressor gene patched encodes a candidate receptor for Sonic hedgehog

TL;DR: It is shown that Re can form a physical complex with a newly cloned vertebrate homologue of the Drosophila protein Smoothened (vSmo), and that vSmo is coexpressed with vPtc in many tissues but does not bind Shh directly.